[Excretion of follicle-stimulating and steroid hormones in patients with uterine cancer during treatment with 17-hydroxyprogesterone caproate].
D015068:17-Ketosteroids / Q000652:urine*; D002208:Caproates / Q000627:therapeutic use; D004967:Estrogens / Q000652:urine*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000652:urine*; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000652:urine
D015068:17-Ketosteroids; D002208:Caproates; D004967:Estrogens; D006908:Hydroxyprogesterones; D005640:Follicle Stimulating Hormone
Ekskretsiia follikulostimuliruiushchego i steroidnykh gormonov u bol'nykh rakom tela matki v protsesse lecheniia 17-oksiprogesteronkapronatom.